SCHEMBL4631302

SCHEMBL4631302

CC(C)(C)OC(=O)N1CCC(NC(=O)N2CCOCC2)(c2ccccc2)CC1

nearest known ligand 0.60

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.60
▸ SMN1; SMN2 Q16637 3/20 0.52
▸ USP2 O75604 1/20 0.52
▸ TSHR P16473 2/20 0.49
▸ ALOX15 P16050 1/20 0.49
▸ ATM Q13315 1/20 0.49
▸ TACR1 P25103 1/20 0.46
▸ GPR119 Q8TDV5 1/20 0.45
▸ RECQL P46063 1/20 0.44
▸ OPRD1 P41143 1/20 0.44
▸ OPRK1 P41145 1/20 0.44
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ EPHX2 P34913 1/20 0.43
▸ CCR5 P51681 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8364745 0.90 TSHR (0.52) ALDH1A1SMN1; SMN2TSHRALOX15ATM
SCHEMBL7600715 0.83 ALDH1A1 (0.60) ALDH1A1TSHRALOX15ATMTACR1
SCHEMBL2269271 0.81 SMN1; SMN2 (0.63) ALDH1A1SMN1; SMN2USP2TSHRALOX15
SCHEMBL6423231 0.80 KMT2A (0.51) ALDH1A1SMN1; SMN2TSHR
SCHEMBL4630124 0.79 TSHR (0.50) ALDH1A1TSHRALOX15ATMTACR1
SCHEMBL8364780 0.79 TSHR (0.50) ALDH1A1TSHRALOX15ATMTACR1
SCHEMBL6422095 0.78 CCR5 (0.42) ALDH1A1TSHRALOX15ATMTACR1
SCHEMBL28872311 0.78 TSHR (0.54) ALDH1A1TSHRALOX15ATMTACR1
SCHEMBL7375713 0.78 TSHR (0.49) ALDH1A1TSHRALOX15ATMTACR1
SCHEMBL6425327 0.78 CCR5 (0.44) TSHRALOX15ATMTACR1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1923391-A1 Substituted heterocyclic compounds, method for preparing same and pharmaceutical compositions containing them. sanofi-aventis (FR) 2008-05-21 — — EP disclosed
EP-1688416-A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them Sanofi-Aventis (FR) 2006-08-09 — — EP disclosed
EP-1156049-B1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them SANOFI AVENTIS (FR) 2005-06-01 — — EP disclosed
EP-1340754-A1 Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them SANOFI-SYNTHELABO (FR) 2003-09-03 — — EP disclosed
EP-0807111-B1 SUBSTITUTED HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SANOFI SYNTHELABO (FR) 2002-08-14 — — EP disclosed
EP-1156049-A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them SANOFI-SYNTHELABO (FR) 2001-11-21 — — EP disclosed
US-6242637-B1 USED IN TREATMENT INVOLVING THE TACHYKININ SYSTEM, SUCH AS PAIN, ALLERGY AND INFLAMMATION, CIRCULATORY, GASTROINTESTINAL, NEUROLOGICAL, AND NEUROPSYCHIATRIC DISORDERS SANOFI-SYNTHELABO (FR) 2001-06-05 — — US disclosed
US-6011154-A Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present SANOFI (FR) 2000-01-04 — — US disclosed
US-5977359-A Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present SANOFI (FR) 1999-11-02 — — US disclosed
US-5869663-A INTERMEDIATES FOR NEUROKININ RECEPTOR ANTAGONISTS SANOFI (FR) 1999-02-09 — — US disclosed
US-5780466-A DISORDERS ASSOCIATED WITH EXCESS TACHYKININS AND ALL NEUROKININ-DEPENDENT DISORDERS; ANALGESICS; RESPIRATORY, GASTROINTESTINAL, UROGENTIAL, IMMUNE, CARDIOVASCULAR AND CNS DISORDERS SANOFI (FR) 1998-07-14 — — US disclosed
US-5641777-A NEUROKININ RECEPTOR ANTAGONIST SANOFI (FR) 1997-06-24 — — US disclosed
WO-1996023787-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SANOFI (FR) 1996-08-08 — — WO disclosed
Send feedback